Artiklar av Emmanouela Roussakis

Pharmaceutical Data Exclusivity in the Light of Access to Clinical Data: Is the EMA oversharing?

https://doi.org/10.53292/62cdf208.5b66823e

Publicerad i Stockholm IP Law Review 2023 #2, september 2024 s. 25–34